Faculty Member – Rachael McCaleb

Rachael McCaleb,  PharmD

Assistant Professor

 

Pharmacy Practice
Phone: (501) 603-1418
Fax: (501) 686-7357
Office: Ed II 6/134C
Email: rmccaleb@uams.edu

Education & Training

Postgraduate Year One Pharmacy Residency, Georgia Regents Medical Center/University of Georgia College of Pharmacy, 2014-2015

Doctor of Pharmacy, University of Arkansas for Medical Sciences College of Pharmacy, Little Rock, Arkansas, 2010-2014

Bachelor of Science in Biology, Arkansas State University, Jonesboro, Arkansas, 2005-2009

Teaching Responsibilities

PHPR 3612 – Drug Information History of Drug Information, Nomenclature/FDA Approval Process, Off Label Drug Use, Tertiary Literature Sources, Secondary Literature Sources, Primary Literature Sources, Article Anatomy, Internet Sources/Apps for DI, Systematic Approach to Answering DI Request, Adverse Drug Reaction and Reporting (12 hours)

PHPR 4625 – Therapeutics I Chronic Kidney Disease (CKD) – Progression Modifying Therapies, CKD – Management of Complications, Benign Prostatic Hyperplasia, Erectile Dysfunction, Urinary Incontinence (5-hours)

PHPR 5733 – Pharmacy Management Managed Care Pharmacy (1-hour)

Clinical Practice

Clinical Specialist, Internal Medicine Team 3A – Univeristy of Arkansas for Medical Sciences Medical Center, Little Rock, AR

Research & Scholarly Interests 

Proton pump inhibitor use and adverse events

Memberships 

American Association of Colleges of Pharmacy (AACP)

American College of Clinical Pharmacy (ACCP)

American Pharmacist Association (APhA)

American Society of Health-Systems Pharmacists (ASHP)

Arkansas Association of Health-System Pharmacist (AAHP)

Arkansas Pharmacists’ Association (APA)

Phi Lambda Sigma Leadership Fraternity

Publications 

McCaleb RV, Clemmons AB, Clark S, Gandhi AS. Clinical outcomes of proton pump inhibitor use in hematology/oncology patients at an academic medical center. Ann Pharmacother. 2016 Apr 18. pii: 1060028016644469. [Epub ahead of print]

Campbell C, McCaleb R., Manasco KB. New Inhaled Antimicrobial Formulations for Use in the Cystic Fibrosis Patient Population. Ann Pharmacother. 2016 Feb;50(2):133-40.

McCaleb R., Maples H., Warren R., Willis D., O’Brien CE. Description of respiratory microbiology of children with long-term tracheostomies. Respir care. 2016 Apr;61(4):447-52.

Curriculum Vitae